{"disease":{"id":"leishmaniasis","name":"Leishmaniasis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"amphotericin-b","indication_name":"Leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"amphotericin-b","indication_name":"Visceral leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Abelcet","generic_name":"AMPHOTERICIN B","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Lipid-based Polyene Antifungal [EPC]","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"miltefosine","indication_name":"American mucocutaneous leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Impavido","generic_name":"MILTEFOSINE","company_name":"Knight Theraps","drug_phase":"marketed","molecular_target":"RAC-alpha serine/threonine-protein kinase","drug_class":"Antileishmanial [EPC]","quality_score":65,"revenue":null,"mechanism":"Impavido works by inhibiting the RAC-alpha serine/threonine-protein kinase, which is essential for the survival of Leishmania parasites."},{"drug_id":"miltefosine","indication_name":"Cutaneous leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Impavido","generic_name":"MILTEFOSINE","company_name":"Knight Theraps","drug_phase":"marketed","molecular_target":"RAC-alpha serine/threonine-protein kinase","drug_class":"Antileishmanial [EPC]","quality_score":65,"revenue":null,"mechanism":"Impavido works by inhibiting the RAC-alpha serine/threonine-protein kinase, which is essential for the survival of Leishmania parasites."},{"drug_id":"miltefosine","indication_name":"Visceral leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Impavido","generic_name":"MILTEFOSINE","company_name":"Knight Theraps","drug_phase":"marketed","molecular_target":"RAC-alpha serine/threonine-protein kinase","drug_class":"Antileishmanial [EPC]","quality_score":65,"revenue":null,"mechanism":"Impavido works by inhibiting the RAC-alpha serine/threonine-protein kinase, which is essential for the survival of Leishmania parasites."},{"drug_id":"pentostam","indication_name":"Leishmaniasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pentostam","company_name":"Sheba Medical Center","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06917040","title":"Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":18404,"lead_sponsor_name":"The Mentor Initiative","has_results":false},{"nct_id":"NCT07358910","title":"Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT00342823","title":"Immunogenetics of Visceral Leishmaniasis","phase":"","overall_status":"COMPLETED","enrollment_count":7000,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT07506967","title":"Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2420,"lead_sponsor_name":"Kenya Medical Research Institute","has_results":false},{"nct_id":"NCT00344084","title":"Surveillance for Leishmaniasis Skin Lesions in Mali","phase":"","overall_status":"COMPLETED","enrollment_count":1593,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03784248","title":"Mediterranean Visceral Leishmaniasis With Leishmania Infantum","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false},{"nct_id":"NCT04268524","title":"Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":832,"lead_sponsor_name":"Medecins Sans Frontieres, Netherlands","has_results":false},{"nct_id":"NCT05602610","title":"Clinical Prognostic Score to Predict Relapse in VL","phase":"","overall_status":"RECRUITING","enrollment_count":741,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT03646981","title":"Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa","phase":"","overall_status":"COMPLETED","enrollment_count":704,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT05386875","title":"Evaluation to Assess the Usability of rK28 for the Diagnosis of Visceral Leishmaniasis in Kenya","phase":"","overall_status":"UNKNOWN","enrollment_count":625,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03013673","title":"Predicting Visceral Leishmaniasis in HIV Infected Patients","phase":"","overall_status":"TERMINATED","enrollment_count":566,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT04003532","title":"LAMP Assay for the Diagnosis of Visceral Leishmaniasis","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Prof. Dawit Wolday","has_results":false},{"nct_id":"NCT03129646","title":"Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":439,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT06793111","title":"Visceral Leishmaniasis in Emilia-Romagna (Leishmania-2019)","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","has_results":false},{"nct_id":"NCT03023111","title":"Miltefosine and GM-CSF in Cutaneous Leishmaniasis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Hospital Universitário Professor Edgard Santos","has_results":false},{"nct_id":"NCT00344188","title":"Diagnosis and Treatment of Leishmania Infections","phase":"","overall_status":"RECRUITING","enrollment_count":289,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03311607","title":"Safety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in Bangladesh","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Medecins Sans Frontieres, Netherlands","has_results":false},{"nct_id":"NCT06692985","title":"Epidemiology of Cutaneous Leishmaniasis in Niger, Mali, Togo : Mapping of Clinical Cases, Species, Reservoirs and Vectors of the Disease","phase":"","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT03993093","title":"Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre","phase":"","overall_status":"COMPLETED","enrollment_count":257,"lead_sponsor_name":"Singh, Ranjan Kumar, M.D.","has_results":false},{"nct_id":"NCT06997159","title":"A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT04342715","title":"A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"University of York","has_results":false},{"nct_id":"NCT03269006","title":"Improved Case Detection and Vector Control for Visceral Leishmaniasis","phase":"NA","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT07504757","title":"LEISH-PED: Study on Leishmaniasis in Children","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Meyer Children's Hospital IRCCS","has_results":false},{"nct_id":"NCT06859619","title":"Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":183,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06746350","title":"Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":165,"lead_sponsor_name":"Armauer Hansen Research Institute, Ethiopia","has_results":false},{"nct_id":"NCT03636659","title":"Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Aurobindo Pharma Ltd","has_results":false},{"nct_id":"NCT05708625","title":"Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":136,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT04500873","title":"Performance of RPA-LF for Cutaneous Leishmaniasis","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Centro Internacional de Entrenamiento e Investigaciones Médicas","has_results":false},{"nct_id":"NCT04799236","title":"Treatment of Mucosal Bolivian Leishmaniasis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Fundacion Nacional de Dermatologia","has_results":false},{"nct_id":"NCT03829917","title":"Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Fundacion Nacional de Dermatologia","has_results":false},{"nct_id":"NCT05533736","title":"Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia","phase":"NA","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Centro Internacional de Entrenamiento e Investigaciones Médicas","has_results":false},{"nct_id":"NCT04699383","title":"Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT05593666","title":"A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":101,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT03641339","title":"Defining Skin Immunity of a Bite of Key Insect Vectors in Humans","phase":"NA","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03969134","title":"A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"University of York","has_results":false},{"nct_id":"NCT06798402","title":"Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Al-Mustafa University College","has_results":false},{"nct_id":"NCT03096457","title":"Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Fundacion Nacional de Dermatologia","has_results":false},{"nct_id":"NCT04841239","title":"Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis","phase":"NA","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Jinnah Sindh Medical University","has_results":false},{"nct_id":"NCT06118749","title":"Leishmania Antigen Rapid Diagnostic Test Proof-of-Concept and Validation Study","phase":"","overall_status":"TERMINATED","enrollment_count":72,"lead_sponsor_name":"Foundation for Innovative New Diagnostics, Switzerland","has_results":false},{"nct_id":"NCT03929016","title":"Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT00381394","title":"A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04504435","title":"Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05957978","title":"LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Drugs for Neglected Diseases","has_results":false},{"nct_id":"NCT05449717","title":"Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Epicentre","has_results":false},{"nct_id":"NCT03445897","title":"Miltefosine Plus IL Pentamidine for Bolivian CL","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Jonathan Berman","has_results":false},{"nct_id":"NCT04888130","title":"Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH)","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Centre Hospitalier de Cayenne","has_results":false},{"nct_id":"NCT06977490","title":"Human Bioequivalence Study of Amphotericin B Liposome for Injection","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Sichuan Huiyu Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06797544","title":"Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Hayder Adnan Fawzi","has_results":false},{"nct_id":"NCT06798415","title":"Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Hayder Adnan Fawzi","has_results":false},{"nct_id":"NCT03303898","title":"ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE -","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nice","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}